EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
11,515 Shares of Merck & Co., Inc. $MRK Acquired by Canandaigua National Trust Co of Florida - Daily Political
Merck & Co., Inc. $MRK Stock Position Cut by Canandaigua National Bank & Trust Co. - Daily Political
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Lowered at Morgan Stanley - Daily Political
Merck & Co., Inc. (NYSE:MRK) Stock Has Consensus Price Target of $146.36
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Raised at JPMorgan Chase & Co. - Stock Observer
Top Pharmaceutical Stocks To Follow Now - October 5th - Markets Daily
Merck & Co., Inc. $MRK Stock Position Decreased by Park National Corp OH
Rockland Trust Co. Lowers Stake in Merck & Co., Inc. $MRK
Top Pharmaceutical Stocks To Follow Now - October 5th - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Bump from JPMorgan Chase & Co.
Merck & Co., Inc. $MRK Stock Sold by Rockland Trust Co. - Stock Observer
Vaxcyte skyrockets on 'near best-case' pneumococcal vaccine data
Merck & Co., Inc. $MRK Stock Position Lowered by MassMutual Private Wealth & Trust FSB
Best Pharmaceutical Stocks To Add to Your Watchlist - October 4th - Stock Observer
Pharmaceutical Stocks To Watch Now - October 3rd - Zolmax
Merck & Co., Inc. $MRK Stake Trimmed by CX Institutional
Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories
Eli Lilly & Co (LLY) Gets a Buy from RBC Capital
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $180.00 - Zolmax
MSD's Phase IIb study of tulisokibart achieves primary endpoint
RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
Promising Pharmaceutical Stocks Worth Watching - September 30th
Andrew Moffs' Market Outlook: Real Estate Stocks - BNN Bloomberg
U.S. import ban on select Canadian goods takes effect - BNN Bloomberg
Recent Investment Analysts' Ratings Changes for Merck & Co., Inc. (MRK) - Daily Political
Merck (MRK) Withdrew a Cancer Filing. Is the Drug's Promise Still Intact?
Best Pharmaceutical Stocks To Follow Now - September 26th - Daily Political
Merck & Co (MRK) Has Billions in Revenue to Defend. Can its Pipeline Do the Job?
Promising Pharmaceutical Stocks To Research - September 28th - Zolmax
Kodiak soars on double phase III win in wet AMD
Merck in License Pact Worth Up to $2.13 Billion With SciBrunch Therapeutics - Update | Morningstar
Merck (MRK) Secures Exclusive Rights to Cancer Drug in $2.13B SciBrunch Agreement
Merck, Daiichi end plans to seek speedy approval of lung cancer ADC
Merck Signs $2.13 Bln License Deal With SciBrunch Therapeutics For KRAS G12D Inhibitor
Merck in License Pact Worth Up to $2.13 Billion With SciBrunch Therapeutics | Morningstar
CAPVAXIVE® Included in Ontario's Publicly Funded Adult Pneumococcal Immunization Program | INN
Daiichi Sankyo, MSD withdraw cancer drug application
Daiichi, Merck withdraw BLA for B7-H3 ADC in small-cell lung cancer | BioWorld
Merck licenses SPR-2015 from China's Scibrunch in $2B+ deal | BioWorld
Promising Pharmaceutical Stocks To Consider - September 27th - Zolmax
Merck (MRK) Withdraws I-DXd Biologics License Application for ES
Merck, Daiichi Sankyo Withdraw Application for Accelerated Approval of Lung Cancer Treatment | Morningstar
J.P. Morgan Sticks to Their Buy Rating for Teva (TEVA)
Merck reveals study success, and possible safety worries, for eye drug hopeful
Merck sees pivotal victory for $3B eye disease prospect
Envestnet Portfolio Solutions Inc. Has $13.56 Million Stock Holdings in Merck & Co., Inc. $MRK
Envestnet Asset Management Inc. Has $513.60 Million Stock Holdings in Merck & Co., Inc. $MRK
DME red flag in Merck Brunello phase III? Surrozen finishes rich | BioWorld
QRG Capital Management Inc. Lowers Holdings in Merck & Co., Inc. $MRK
Healthcare Stocks To Add to Your Watchlist - September 23rd - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Upgraded at Wall Street Zen - Zolmax
State Street Corp Has $15.57 Billion Position in Merck & Co., Inc. $MRK
Bladder Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight | ABNewswire
Merck's KEYTRUDA QLEX Approved In Japan For Subcutaneous Use
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)
Merck & Co., Inc. (NYSE:MRK) Upgraded by Wall Street Zen to Buy Rating - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Stock Rating Upgraded by Wall Street Zen
Promising Healthcare Stocks To Consider - September 19th - Markets Daily
Merck (MRK) Stock: Surge as HIV Health Campaign Launches at USCHA 2026
Nykredit A S Invests $92.32 Million in Merck & Co., Inc. $MRK
Top Pharmaceutical Stocks Worth Watching - September 17th - Markets Daily
Merck & Co. (MRK) is Building a Stronger Future Beyond Its Keytruda Franchise
Oncology Tie-Up and Blockchain Pilot Might Change The Case For Investing In Merck (MRK)
Merck & Co Inc's Dividend Analysis
RBC Capital Sticks to Their Buy Rating for AstraZeneca (AZN)
RBC Capital Sticks to Their Buy Rating for Roche Holding AG (RHHVF)
RBC Capital Sticks to Their Buy Rating for AbbVie (ABBV)
GlaxoSmithKline (GSK) Gets a Hold from RBC Capital
RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)
RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)
RBC Capital Keeps Their Hold Rating on Novartis AG (NOVN)
RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
Congresswoman Bets on Elon Musk, Warren Buffett: Here's the Latest Stock Transactions
Top Pharmaceutical Stocks To Research - September 14th - Daily Political
Wall Street Zen Downgrades Merck & Co., Inc. (NYSE:MRK) to Hold - Stock Observer
Merck & Co., Inc. (MRK) to Issue Quarterly Dividend of $0.85 on October 7th - Zolmax
Pharmaceutical Stocks To Keep An Eye On - September 13th - Daily Political
Pharmaceutical Stocks To Follow Today - September 12th - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $161.00 - Daily Political
7,741 Shares in Merck & Co., Inc. $MRK Bought by Talon Private Wealth LLC
Smith Chas P & Associates PA Cpas Has $46.21 Million Stake in Merck & Co., Inc. $MRK - Daily Political
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
The Manufacturers Life Insurance Company Has $266.40 Million Position in Merck & Co., Inc. $MRK
Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages
IPG Investment Advisors LLC Lowers Position in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Sold by Corient Private Wealth LP
Rep. Maria Elvira Salazar Buys Merck & Co., Inc. (NYSE:MRK) Stock
RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)
RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.9% - Should You Sell?
MSD opens 2.5 lakh sqft technology centre in Hyderabad
MerckCo News
Samsung Electronics Stock Price Forecast 2026–2027: Can Record Q3 Profit Extend the AI Rally?
GBP/USD Forecast: Can Sterling Hold 1.32 as Fed Rate-Hike Bets Rise?
AUD to USD Forecast 2026–2030: Can the Aussie Reclaim 0.71 After the RBA’s Fourth Rate Hike?
USD/CAD Forecast 2026–2030: Can Fed–BoC Rate Divergence Push the Pair Above 1.42?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Latest news
Show more
EUR/USD Near 17-Month Lows as French Fiscal Concerns Fuel Dollar Strength
Samsung Q3 Operating Profit Jumps Nearly Ninefold to Record 107.4 Trillion Won as Memory Shortage Deepens
Oil Price Today: Crude Rebounds as Middle East Attacks Raise Supply Fears
TSMC Q3 Revenue Jumps 51%, Beats Estimates as AI Chip Demand Supports Record Sales
Bitcoin Price Today Falls Below $83,000 as $696 Million Liquidation Wave Hits Crypto Market
